Please login to the form below
epigenetics
This page shows the latest epigenetics news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca to explore link between epigenetics and respiratory diseases
AstraZeneca to explore link between epigenetics and respiratory diseases. Joins forces with Asthma UK, the British Lung Foundation and MRC Technology. ... Epigenetics are changes in the expression of genes attributed to lifestyle factors affecting the
Latest news
-
Biogen buys into Rodin's Alzheimer's candidate
Biogen buys into Rodin's Alzheimer's candidate. And may acquire the epigenetics-focused Massachusetts firm. ... Biogen has its own research programme in neuronal epigenetic research, according to Samantha Budd Haeberlein, Biogen's vice president of
-
Novartis' Farydak gets nod for myeloma in Europe
Novartis says its approval marks "the first time an HDAC inhibitor with epigenetic activity is available in the EU," providing a much-needed additional line of therapy for patients with aggressive
-
Celgene to acquire biotech firm Quanticel Pharmaceuticals
Through the agreement, Celgene will have full access to Quanticel's proprietary platform for the single-cell genomic analysis of human cancer, alongside Quanticel's lead programmes that target specific epigenetic
-
Novartis pays $16bn for GSK's oncology portfolio
on cancer immunotherapy, epigenetics and tumour environment.
-
Selfie campaign boosts cancer funds
A selfie of thanks: Imperial College's Epigenetics Unit, including scientific fellow Dr James Flanagan. ... Breast Cancer Campaign-funded scientists showed their thanks by posting their own selfies, including a group shop of scientific fellow Dr James
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Deal Watch November 2016
licence, collaboration. 207.5. Proterosos biostructures/ Merck &Co (MSD). second collaboration to develop small molecules against an additional epigenetic target for various cancers.
-
Opening up innovation
So that is really about the late-stage portfolio. We [are still] focused on three areas in oncology.” These are cancer epigenetics, immuno-oncology and cell and gene therapy in oncology. “
-
Deal Watch January 2016
Tensha has developed an epigenetic technology that disrupts bromodomain and extra terminal domain (BET) proteins in order to develop potential treatments for cancer. ... 535. Rodin/ Biogen. Collaboration. Multi-year neuronal epigenetics research
-
Deal Watch October 2015
Proteros' epigenetics technology and structure guided discovery platform for oncology targets (discovery).
-
Pharma deals in August 2015
This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery company, Constellation Pharmaceuticals.
More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Professor Thomas Cech joins Storm Therapeutics
mature into a world leading therapeutics company targeting RNA epigenetic modulation.”.
-
Storm Therapeutics bolsters its team
As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells. ... Keith Blundy, chief executive officer of Storm Therapeutics,
-
Storm Therapeutics strengthens its board
RNA epigenetic modulation is an exciting area of science with real potential to deliver new targeted cancer therapies. ... We look forward to Paul’s input on development and positioning of Storm’s emerging RNA epigenetics platform and programmes.”.
-
Rubius Therapeutics strengthens senior team
He most recently served as the senior vice president and head of the cancer epigenetics department at GlaxoSmithKline, where he was responsible for overall strategy, as well as identification and validation ... of new epigenetic targets and advancing
-
Paul Stockdale joins Oxford BioDynamics as CFO
A spin-out from Oxford University, Oxford BioDynamics focuses on the discovery and development of epigenetic biomarkers based on regulatory genome architecture.
More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.
Featured jobs
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England says yes to Roche's Hemlibra
- Moving annual total (MAT)
- Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Communiqué Awards 2018: Winners in pictures - Communiqué Awards 2016
- May’s Brexit plan cautiously welcomed by biopharma sector
- Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Fishawack acquires brand communications agency Healthcircle
- Roche keeps Venclexta train rolling with new leukaemia filing
- Pfizer builds gap between pharma and consumer health units
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
- The rise of vertical integration in the US payer landscape
- Is it a solution to addressing the challenges of the value-based marketplace?...
- Creativity has lost its worth
- Creativity has lost its worth, and sadly it is undermining effectiveness...
Quick links
Infographics
